March 25, 2019 – Several moves that could change the way prescription drug marketing and communications are conducted are being made in Washington, with the House Ways and Means Committee about to begin markup on a tax measure that could include eliminating the deductibility of drug marketing costs, and the Office of Management and Budget […]
Read more Jan. 16, 2019 – Sens. Jeanne Shaheen (D-N.H.) and Elizabeth Warren (D-Mass.) have co-authored a bill that would “deny the deduction for advertising and promotional expenses for prescription drugs.” The bill, announced Jan. 11, is titled the “End Taxpayer Subsidies for Drug Ads Act.” “This bill raises significant First Amendment questions,” pointed out Jon Bigelow, […]
Read more By John Kamp, Coalition for Healthcare Communication Executive Director May 11, 2017 – Although no one seems to like the new Trump/Ryan healthcare bill, House staffers now (finally) are preparing for the next big Republican effort – overhauling the tax system for both individuals and corporations. Like healthcare, everyone seems to agree that an overhaul […]
Read more
By John Kamp, Executive Director, Coalition for Healthcare Communication [Editor’s Note: This “The Final Word” column appeared in the February 2017 edition of MedAdNews and is reprinted with permission.] As a public official preparing for international negotiations, I was taught by the U.S. State Department to always know exactly what you want and what you’re […]
Read more
Nov. 28, 2016 – Although President-elect Donald Trump was not who the Coalition for Healthcare Communication was preparing for in 2017, the organization will stay true to its mission of promoting and protecting the free flow of healthcare information under the Trump administration, according to Coalition Executive Director John Kamp, who spoke at the recent […]
Read more Nov. 11, 2016 – Post-election report from Coalition for Healthcare Communication Executive Director John Kamp: The pollsters and pundits sure got it wrong. As they look back to correct their errors, the new reality of a Trump Administration and a Republican-controlled House and Senate provides some clues to the future of our industry. As our […]
Read moreJan. 15, 2013 – If 2012 – with its high number of new drug approvals, senior staff stability within the FDA and the Department of Health & Human Services (HHS) and a definitive decision about the Affordable Care Act (ACA) – is an indicator, then the 2013 Washington outlook for pharmaceutical companies is promising. However, […]
Read moreDec. 12, 2012 – An ongoing push to eliminate the tax deduction for prescription drug advertising may actually move forward for a number of reasons, according to Jim Davidson, Executive Director, The Advertising Coalition, who spoke at a recent Medivo BTP “Leadership Series” meeting held at The New York Times. “Jim Davidson”s update on Capitol Hill’s approach […]
Read moreBy John Kamp, Executive Director, Coalition for Healthcare Communication May 18, 2012 — Sen. Claire McCaskill (D-Mo.) told a group of senior advertising executives this morning at the AAAA”s New York offices that elimination of the deduction for marketing expenses remains possible, especially during the “lame duck” session of Congress following the November election. […]
Read more